Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 43,728 | 27,332 | N/A | N/A |
| TOTAL | $45,071 | $27,339 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 77 | N/A | N/A | N/A |
| Other Non-Current Assets | 513 | 0 | 0 | 0 |
| TOTAL | $590 | $N/A | $N/A | $N/A |
| Total Assets | $45,661 | $27,339 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 202 | 69 | 0 | 0 |
| Accrued Expenses | 1,596 | 469 | N/A | N/A |
| Other current liabilities | N/A | 1,483 | N/A | N/A |
| TOTAL | $1,996 | $2,021 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 101,206 | 40,341 | 0 | 0 |
| TOTAL | $97,870 | $35,991 | $N/A | $N/A |
| Total Liabilities | $99,866 | $38,012 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 2,000 | 2,000 | N/A | N/A |
| Retained earnings | -56,842 | -12,784 | N/A | N/A |
| Other shareholders' equity | 637 | 111 | 0 | 0 |
| TOTAL | $-54,205 | $-10,673 | $N/A | $N/A |
| Total Liabilities And Equity | $45,661 | $27,339 | $0 | $0 |